💼 Business · The Washington Post
Lyme disease vaccine shows 70 percent efficacy, Pfizer says - The Washington Post
If approved by regulators, it could become the only Lyme disease vaccine available for people — although it would not be the first.
Four doses of an experimental vaccine to protect against Lyme disease reduced the number of tick-borne infections by more than 70 percent, according to Pfizer and Valneva, the pharmaceutical companie…
This article is republished through the USVI News affiliate desk. Reporting, analysis, and viewpoints are those of the original publisher and do not necessarily reflect USVI News.